MedPath

The Dynamics of Human Atrial Fibrillation

Completed
Conditions
Atrial Fibrillation
Atrial Tachyarrhythmia
Registration Number
NCT01008722
Lead Sponsor
University of California, San Diego
Brief Summary

The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
98
Inclusion Criteria
  • Subjects will be patients undergoing electrophysiology study and ablation for paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1 anti-arrhythmic drug.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival Free of Atrial Fibrillation6 -12 months

Using data from cardiac implanted devices when possible, with recurrence defined as 1% recurrence, or data from intermittent 24-72 hour ambulatory ECGs, with recurrence defined as \>30 seconds.

Secondary Outcome Measures
NameTimeMethod
Termination or Slowing of Atrial Fibrillation During Ablationacute

Using data from electrophysiological study, to determine termination of AF into sinus rhythm or organized atrial tachycardia. or slowing by 10% in cycle length measured on the coronary sinus.

Trial Locations

Locations (2)

University of California, San Diego

🇺🇸

La Jolla, California, United States

VA San Diego Medical Center

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath